三共研究所年報

• Material Type: 雑誌
• Title: 三共研究所年報
• Title Transcription: サンキョウ ケンキュウジョ ネンポウ
• Volume: 53巻-58巻 2001年-2006年 (以後廃刊)
• Author Heading: 三共株式会社 サンキョウ カブシキ ガイシャ ( 00298901 )Authorities
• Publication, Distribution, etc.: 東京 : 三共研究開発統轄本部
• Publication Date: 2001-2006
• Publication Date (W3CDTF): 2001-2006
• Year and volume of publication: 15巻 (昭和38年12月)-v. 58 (2006)
• Size: 28cm
• Alternative Title: Annual report of Sankyo Research Laboratories Annual report of Sankyo Research Laboratories; Sankyo Kenkyusho nenpo Sankyo Kenkyusho nenpo
• ISSN (Periodical Title): 0080-6064; 1341-741X
• ISSN-L (Periodical Title): 0080-6064; 1341-741X
• Place of Publication (Country Code): JP
• Text Language Code: eng; jpn
• NDLC: ZS51
• Note (General): 本タイトル等は最新号による; 大きさの変更あり
• Holding library: 国立国会図書館
• Call No.: Z19-314
• Replaces: 継続前 : 高峰研究所年報 / 三共株式会社高峰研究所 [編]; https://ndlsearch.ndl.go.jp/books/R100000002-I000000014377
• Data Provider (Database): 国立国会図書館 : 国立国会図書館蔵書; https://ndlsearch.ndl.go.jp
• Bibliographic ID (NDL): 000000009404; http://id.ndl.go.jp/bib/000000009404
• Cataloging Rule: Nippon Cataloguing Rules 1987 Revised Edition

Table of Contents

Olmesartan Medoxomil, a Novel Potent Angiotensin 2 Blocker

Novel Synthesis of Carbapenams Using a Palladium Catalyst

Bioinformatics in Genome-based Drug Discovery: Research Activities at Sankyo

Synthesis of 14C-Labeled Simeconazole

CS-758, a New Triazole Antifungal Agent: In Vivo Antifungal Activity against Experimental Candidiasis, Aspergillosis, and Cryptococcosis

Leustroducsins, Low Molecular Weight Thrombopoietic Agents: Discovery, Biological Properties and Total Synthesis

In Situ Observation of Dehydration of 1β-Methylcarbapenem CS-834 Hydrate by X-ray Analysis

ANGPTL3, a Novel Lipid Metabolism Modulator

Synthetic Study and Development of New Antibiotics, Globomycin and Its Analogues

Toxicogenomics--New Approach for Drug Development

Cardiovascular drug development in Sankyo

Immunotoxicity assessment in preclinical study of pharmaceuticals

In Vitro and In Viro screening for QT prolongation in the early stages of drug development

Utilization of DDS in drug development